CardioNet, Inc.
CardioNet, Inc. Files Resale Registration Statement
Published in Cardiovascular Device Liability Week, July 20th, 2008
CardioNet, Inc. (NASDAQ:BEAT), a leading wireless medical technology company with an initial focus on the diagnosis and monitoring of cardiac arrhythmias, today filed a resale registration statement with the SEC related to the shares that were underlying the Mandatorily Redeemable Convertible Preferred Stock issued in March 2007. The shares being registered remain subject to lock-up agreements entered into in connection with CardioNet's IPO, pursuant to which the holders have agreed not to sell such shares until at least September 15, 2008.
Marty Galvan, CardioNet's Chief Financial Officer, commented: "We have filed this registration statement to satisfy a contractual...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Heart Attack
Back From the Dead: Cardiac Arrest Victim Salutes His Rescuer - Medicare and Medicaid
Young Man With Severe Disabilities Wins Right to Services From State Enabling Him to Live At Home - Abbott
FDA Approves Abbott's XIENCE V Drug Eluting Stent - Abdominal Aortic Aneurysm
Studies from J.B. Dimick and colleagues reveal new findings on abdominal aortic aneurysm - Abdominal Aortic Aneurysm
Study data from University of Copenhagen update understanding of abdominal aortic aneurysm - Abdominal Aortic Aneurysm
Surgeons Role in Abdominal Aortic Aneurysms Mortality Examined - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
